Literature DB >> 17038631

Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.

Ruijie Liu1, Mohammad R Hojjati, Cecilia M Devlin, Inge H Hansen, Xian-Cheng Jiang.   

Abstract

OBJECTIVE: PLTP and apoE play important roles in lipoprotein metabolism and atherosclerosis. It is known that formation of macrophage-derived foam cells (which highly express PLTP and apoE) is the critical step in the process of atherosclerosis. We investigated the relationship between PLTP and apoE in macrophages and the atherogenic relevance in a mouse model. METHODS AND
RESULTS: We transplanted PLTP-deficient mouse bone marrow into apoE-deficient mice (PLTP-/- --> apoE-/-), creating a mouse model with PLTP deficiency and apoE expression exclusively in the macrophages. We found that PLTP-/- --> apoE-/- mice have significantly lower PLTP activity, compared with controls (WT --> apoE-/-; 20%, P<0.01). On a Western diet, PLTP-/- --> apoE-/- mice have significantly lower plasma apoE than that of WT --> apoE-/- mice (63%, P<0.001), and PLTP-deficient macrophages secrete significantly less apoE than WT macrophages (44%, P<0.01). Moreover, PLTP-/- --> apoE-/- mice have significantly higher plasma cholesterol (98%, P<0.001) and phospholipid (107%, P<0.001) than that of WT --> apoE-/- mice, thus increasing atherosclerotic lesions in the aortic arch and root (403%, P<0.001), as well as the entire aorta (298%, P<0.001).
CONCLUSIONS: Macrophage PLTP deficiency causes a significant reduction of apoE secretion from the cells, and this in turn promotes the accumulation of cholesterol in the circulation and accelerates the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038631     DOI: 10.1161/01.ATV.0000249721.96666.e5

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

1.  Structural basis of the lipid transfer mechanism of phospholipid transfer protein (PLTP).

Authors:  Meng Zhang; Xiaobo Zhai; Jinping Li; John J Albers; Simona Vuletic; Gang Ren
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-06-05       Impact factor: 4.698

2.  PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity.

Authors:  Daniel Seung Kim; Amber A Burt; Jane E Ranchalis; Simona Vuletic; Tomas Vaisar; Wan-Fen Li; Elisabeth A Rosenthal; Weijiang Dong; Jason F Eintracht; Arno G Motulsky; John D Brunzell; John J Albers; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2015-05-25       Impact factor: 5.922

Review 3.  Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Authors:  John J Albers; Simona Vuletic; Marian C Cheung
Journal:  Biochim Biophys Acta       Date:  2011-06-28

4.  Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.

Authors:  Takashi Kuwano; Xin Bi; Eleonora Cipollari; Tomoyuki Yasuda; William R Lagor; Hannah J Szapary; Junichiro Tohyama; John S Millar; Jeffrey T Billheimer; Nicholas N Lyssenko; Daniel J Rader
Journal:  J Lipid Res       Date:  2017-01-30       Impact factor: 5.922

5.  An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux.

Authors:  John F Oram; Gertrud Wolfbauer; Chongren Tang; W Sean Davidson; John J Albers
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

6.  Human apoA-I increases macrophage foam cell derived PLTP activity without affecting the PLTP mass.

Authors:  Marius R Robciuc; Jari Metso; Anca Sima; Christian Ehnholm; Matti Jauhiainen
Journal:  Lipids Health Dis       Date:  2010-06-09       Impact factor: 3.876

7.  The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism.

Authors:  Xian-Cheng Jiang; Weijun Jin; Mahmood M Hussain
Journal:  Nutr Metab (Lond)       Date:  2012-08-16       Impact factor: 4.169

Review 8.  Role of phospholipid transfer protein in high-density lipoprotein- mediated reverse cholesterol transport.

Authors:  Amirfarbod Yazdanyar; Calvin Yeang; Xian-Cheng Jiang
Journal:  Curr Atheroscler Rep       Date:  2011-06       Impact factor: 5.113

9.  Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.

Authors:  Anouar Hafiane; John K Bielicki; Jan O Johansson; Jacques Genest
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.